{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.23 vs. cons $2.17",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Pre-tax variable investment income (VII)",
      "prediction": "IN-LINE",
      "answer": "pred ~$245M vs. cons $245M",
      "confidence": "HIGH"
    },
    {
      "kpi": "Group Benefits adjusted earnings",
      "prediction": "BEAT",
      "answer": "pred ~$415M vs. cons $395M",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Full-year pre-tax VII",
      "prediction": "BETTER",
      "answer": "guide ~$1.60B vs. cons $1.55B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Full-year adjusted EPS growth",
      "prediction": "BETTER",
      "answer": "guide ~11% vs. cons 10% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "RIS adjusted earnings",
      "prediction": "UNCHANGED",
      "answer": "guide ~$1.70B vs. cons $1.70B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "MIM adjusted earnings",
      "prediction": "UNCHANGED",
      "answer": "guide ~$260M vs. cons $260M (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.0,
  "day5_path": "STABILIZE",
  "day5_rationale": "A modest EPS beat of ~$2.23 versus $2.17 and VII near ~$245M should support an initial positive reaction, but retained FY2026 VII guidance of ~$1.60B versus ~$1.55B consensus is a reaffirmation rather than a material raise; limited out-period estimate upside should leave the 5-day residual near +1.0% after a +1.8% day-1 move.",
  "day5_confidence": "MEDIUM"
}